Has a drug for Alzheimer’s finally been found? Biogen surged 21% After Positive topline results
Biogen Inc. surged after an Alzheimer’s drug known as BAN2401 phase 2b showed positive results in a large clinical trial, raising hopes for early disease’s patients. According to Biogen and More...
Why Jim Cramer Is Staying Away from Biotechs
Jim Cramer on his CNBC Mad Money program was bullish on biotechs all summer. This was after a surplus of biotech IPOs flooded the market in the spring, and the sector bottomed. Biotechs rebounded with a vengeance More...
Jim Cramer Says Janet Yellen Made the Worst Stock Call Ever
Jim Cramer discussed his stock picks on CNBC’s Mad Dash segment. Cramer said Fed Chief Janet Yellen made the worst stock call he has ever heard when she made bearish statement about the biotech sector More...
8 Jim Cramer ‘Buys’ In the Fed Fallout
Actually, the Fed “fallout” wasn’t the crisis many expected. For years, the prophets of doom on Wall Street were terrified of that fateful day the Fed would cease its bond buying. They More...
Credit Suisse: Copaxone sales to plunge 90%
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion for Laquinimod. – Copaxone – Teva Pharmaceutical Industries More...